Category: Uncategorized

CORMEDIX INC. ANNOUNCES RESUBMISSION of NEW DRUG APPLICATION FOR DEFENCATH

Written by Sam Nelson on February 28, 2022

Berkeley Heights, NJ – February 28, 2022 – CorMedix Inc. (Nasdaq:…

CORMEDIX TO PARTICIPATE IN UPCOMING JANUARY CONFERENCES

Written by Sam Nelson on January 4, 2022

Berkeley Heights, NJ – January 4, 2022 – CorMedix Inc. (Nasdaq: CRMD),…

CORMEDIX INC. REPORTS THIRD QUARTER 2021 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

Written by Sam Nelson on November 9, 2021

Conference Call Scheduled for Today at 4:30 p.m. Eastern Time…

CorMedix Inc. to Report Third Quarter 2021 Financial Results and Provide a Corporate Update on November 9

Written by Sam Nelson on November 2, 2021

Berkeley Heights, NJ – November 2, 2021 – CorMedix Inc. (Nasdaq:…

CORMEDIX INC. ANNOUNCES ABSTRACTS AT UPCOMING CONFERENCES SHOWING PATIENT OUTCOMES AND ECONOMIC BURDEN OF CRBSI

Written by Sam Nelson on October 20, 2021

Berkeley Heights, NJ – October 20, 2021 – CorMedix Inc. (Nasdaq:…

CORMEDIX INC. ANNOUNCES EXECUTIVE LEADERSHIP CHANGES

Written by Sam Nelson on October 4, 2021

Berkeley Heights, NJ – October 4, 2021 – CorMedix Inc. (Nasdaq:…

CORMEDIX INC. ANNOUNCES REGULATORY UPDATE

Written by Sam Nelson on September 7, 2021

Berkeley Heights, NJ – September 7, 2021 – CorMedix Inc. (Nasdaq:…

CORMEDIX INC. REPORTS SECOND QUARTER AND SIX MONTH 2021 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

Written by Sam Nelson on August 12, 2021

Conference Call Scheduled for Today at 4:30 p.m. Eastern Time…

CorMedix Inc. to Report Second Quarter 2021 Financial Results and Provide a Corporate Update on August 12

Written by Sam Nelson on July 28, 2021

Berkeley Heights, NJ – July 28, 2021 – CorMedix Inc. (Nasdaq:…

CorMedix Inc. Completes Sale of $1.3 Million of NOL Tax Benefits Through The New Jersey Economic Development Authority Program

Written by Sam Nelson on June 10, 2021

Berkeley Heights, NJ – June 10, 2021 – CorMedix Inc. (Nasdaq:…

CorMedix Inc. to Participate in Fireside Chat at the JMP Securities Life Sciences Conference

Written by Sam Nelson on June 9, 2021

Berkeley Heights, NJ – June 9, 2021 – CorMedix Inc. (Nasdaq:…

CorMedix Inc. to Present at the Jefferies Virtual Healthcare Conference

Written by Sam Nelson on May 27, 2021

Berkeley Heights, NJ – May 27, 2021 – CorMedix Inc. (Nasdaq:…

CorMedix Inc. Reports First Quarter 2021 Financial Results and Provides Business Update

Written by Sam Nelson on May 13, 2021

Conference Call Scheduled for Today at 4:30 p.m. Eastern Time…

CorMedix Inc. to Report First Quarter 2021 Financial Results and Provide a Corporate Update on May 13

Written by Sam Nelson on May 5, 2021

Berkeley Heights, NJ – May 5, 2021 – CorMedix Inc. (Nasdaq:…

CORMEDIX INC. TO PARTICIPATE AT THE 7th ANNUAL TRUIST SECURITIES LIFE SCIENCES SUMMIT

Written by Sam Nelson on April 28, 2021

Berkeley Heights, NJ – April 28, 2021 – CorMedix Inc. (Nasdaq:…

CORMEDIX HAS MEETING WITH FDA ON DEFENCATH CATHETER LOCK SOLUTION NDA

Written by Sam Nelson on April 14, 2021

Berkeley Heights, NJ — April 14, 2021 — CorMedix Inc….

CORMEDIX INC. REPORTS FOURTH QUARTER AND FULL YEAR 2020 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

Written by Sam Nelson on March 30, 2021

Conference Call Scheduled for Today at 4:30 p.m. Eastern Time…

CorMedix Inc. to Report Fourth Quarter and Fiscal Year 2020 Financial Results and Provide a Corporate Update on March 30

Written by Sam Nelson on March 23, 2021

Berkeley Heights, NJ – March 23, 2021 – CorMedix Inc. (NASDAQ: CRMD),…

CorMedix Approved to Sell $1.3 Million of NOL Tax Benefits Through The New Jersey Economic Development Authority Program

Written by Sam Nelson on March 15, 2021

Berkeley Heights, NJ – March 15, 2021 – CorMedix Inc. (NASDAQ:…

CorMedix Inc. to Host Regulatory Update Conference Call

Written by Sam Nelson on March 8, 2021

Berkeley Heights, NJ – March 8, 2021 – CorMedix Inc. (NASDAQ:…